BOSTON – Biopharmaceutical company Parexel is collaborating with Sanofi, a research and pharmaceutical company, to study how data collected from several sensors and wearable devices can be streamlined into a single, scalable data system to provide insights. “We believe we have a strong opportunity to streamline and automate data collection from multiple devices, collect high-quality data remotely and generate meaningful results, all while reducing burden on patients and sites, as well as lowering costs,” said Xavier Flinois, president of Parexel Informatics, in a statement. Currently, Parexel and Sanofi are collaborating on a pilot study using Parexel’s recently launched patient sensor to demonstrate the scientific and medical viability of wearables. In an ongoing single-site study, patient data is being collected remotely and simultaneously via multiple wearable devices. Publication of final study results is expected in the near future.
You are here: / / Sanofi, Parexel team to study wearables impact on data collection for clinical trials